With an aging population now an irrefutable reality in Japan, concerns about the health and well-being of older adults have come to the forefront of public health dialogue. Older adults are especially at risk for fragility ...
12 minutes ago
0
0
Researchers have identified a promising new therapeutic strategy for autism spectrum disorder (ASD). A research team led by Director KIM Eunjoon of the IBS Center for Synaptic Brain Dysfunctions has now identified a promising ...
12 minutes ago
0
0
How can we combat the growing global health crisis of antibiotic resistance? At Leiden University, researchers are tackling this issue from multiple angles. Ph.D. candidate Vladyslav Lysenko develops and redesigns new antibiotic ...
32 minutes ago
0
0
Over the past few years, GLP-1 drugs have transformed the treatment landscape for obesity and type 2 diabetes. By mimicking a hormone that helps regulate blood sugar, slows digestion and curbs appetite, these medications ...
An investigator at the Icahn School of Medicine at Mount Sinai has received international recognition for innovative imaging research that may help physicians identify patients at increased risk of chronic kidney disease ...
52 minutes ago
0
0
Wearing a cooling cap for 30 minutes may improve a person's sense of well-being, according to a new study by Penn State researchers. In a recent publication in Acta Psychologica, the researchers demonstrated that head cooling ...
1 hour ago
0
0
Heat could pose a danger to workers at the upcoming FIFA World Cup, according to a new study from the University of Georgia.
1 hour ago
0
0
Three commercially available radiology AI systems have shown the potential to flag early signs of breast cancer up to six years before a diagnosis, according to a study published in Radiology.
1 hour ago
0
0
In one of the largest studies to date, researchers examined the relationship between long-term air pollution exposure and coronary atherosclerosis and found that even at moderate levels, long-term exposure to air pollution ...
1 hour ago
0
0
The U.S. Food and Drug Administration has approved Shionogi's Xocova (ensitrelvir), an oral antiviral, for postexposure prophylaxis (PEP) of COVID‑19 in adults and adolescents aged 12 years and older.
1 hour ago
0
0
